Total Payments
$2,776
2023 Payments
$144.69
Companies
33
Transactions
150
Medicare Patients
12,395
Medicare Billing
$489,210
Payment Breakdown by Category
Food & Beverage$2,667 (96.1%)
Education$108.76 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,667 | 147 | 96.1% |
| Education | $108.76 | 3 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $285.51 | 17 | $0 (2022) |
| AbbVie Inc. | $275.23 | 17 | $0 (2023) |
| Allergan, Inc. | $227.62 | 9 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $200.52 | 7 | $0 (2019) |
| Novo Nordisk Inc | $196.55 | 15 | $0 (2022) |
| Lilly USA, LLC | $169.25 | 8 | $0 (2023) |
| Amgen Inc. | $164.66 | 9 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $160.26 | 8 | $0 (2022) |
| PFIZER INC. | $158.67 | 11 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $117.84 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $144.69 | 9 | AbbVie Inc. ($44.49) |
| 2022 | $579.10 | 32 | ABBVIE INC. ($183.18) |
| 2021 | $26.00 | 2 | PFIZER INC. ($26.00) |
| 2020 | $134.16 | 9 | PFIZER INC. ($40.28) |
| 2019 | $599.09 | 27 | GlaxoSmithKline, LLC. ($163.19) |
| 2018 | $529.55 | 28 | Allergan Inc. ($132.50) |
| 2017 | $763.61 | 43 | Merck Sharp & Dohme Corporation ($145.16) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/27/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Oncology | ||||||
| 07/13/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Neuroscience | ||||||
| 06/22/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Diabetes | ||||||
| 05/02/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Neuroscience | ||||||
| 03/23/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardio-renal | ||||||
| 11/03/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Cardio-renal | ||||||
| 09/12/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: RESPIRATORY | ||||||
| 09/08/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2022 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $31.87 | General |
| Category: HFCWO | ||||||
| 08/25/2022 | Novo Nordisk Inc | Rybelsus (Drug), Tresiba, Ozempic | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Diabetes | ||||||
| 08/22/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Neuroscience | ||||||
| 08/18/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: RESPIRATORY | ||||||
| 08/17/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardio-renal | ||||||
| 08/02/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 881 | 1,008 | $104,000 | $41,710 |
| 2022 | 48 | 4,469 | 6,889 | $393,309 | $153,210 |
| 2021 | 39 | 3,541 | 5,839 | $385,394 | $154,005 |
| 2020 | 36 | 3,504 | 5,980 | $404,714 | $140,285 |
Total Patients
12,395
Total Services
19,716
Medicare Billing
$489,210
Procedure Codes
143
All Medicare Procedures & Services
143 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 199 | $45,167 | $16,365 | 36.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 111 | 111 | $23,865 | $13,197 | 55.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 60 | $9,664 | $3,321 | 34.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 29 | 29 | $3,130 | $2,086 | 66.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 106 | 106 | $3,395 | $1,781 | 52.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 36 | 36 | $2,214 | $592.56 | 26.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 40 | 40 | $2,284 | $524.80 | 23.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $1,297 | $493.44 | 38.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $449.40 | $440.44 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 43 | $2,412 | $431.17 | 17.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 42 | 42 | $2,449 | $424.35 | 17.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 47 | 49 | $539.00 | $403.20 | 74.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 34 | 34 | $1,119 | $300.56 | 26.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 40 | 40 | $1,234 | $296.79 | 24.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 28 | $655.99 | $266.56 | 40.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 17 | 18 | $577.80 | $222.30 | 38.5% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 36 | 36 | $982.80 | $198.10 | 20.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 36 | 36 | $756.00 | $177.80 | 23.5% |
| 85610 | Blood test, clotting time | Office | 2023 | 12 | 39 | $1,712 | $163.80 | 9.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 21 | $97.50 | $23.24 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 267 | 738 | $146,124 | $56,396 | 38.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 158 | 158 | $33,970 | $19,535 | 57.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 157 | 286 | $38,610 | $15,939 | 41.3% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 27 | 27 | $8,523 | $6,819 | 80.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 80 | 81 | $7,811 | $5,473 | 70.1% |
About Dr. Celso Chavez, MD
Dr. Celso Chavez, MD is a Family Medicine healthcare provider based in Lewiston, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386795565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Celso Chavez, MD has received a total of $2,776 in payments from pharmaceutical and medical device companies, with $144.69 received in 2023. These payments were reported across 150 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,667).
As a Medicare-enrolled provider, Chavez has provided services to 12,395 Medicare beneficiaries, totaling 19,716 services with total Medicare billing of $489,210. Data is available for 4 years (2020–2023), covering 143 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lewiston, ID
- Active Since 01/15/2007
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386795565
Products in Payments
- TRELEGY ELLIPTA (Drug) $201.77
- LINZESS (Drug) $139.23
- BELSOMRA (Drug) $124.80
- AJOVY (Drug) $117.84
- UBRELVY (Drug) $107.07
- QULIPTA (Drug) $101.44
- TOUJEO (Drug) $82.72
- Aimovig (Biological) $82.60
- TRULICITY (Drug) $78.96
- ENTRESTO (Drug) $78.38
- Victoza (Drug) $74.91
- ELIQUIS (Drug) $73.99
- SPY Technology (Device) $68.36
- Kerendia (Drug) $60.80
- CHANTIX (Drug) $57.91
- Tresiba (Drug) $54.48
- Yupelri (Drug) $50.00
- Trintellix (Drug) $49.38
- JANUVIA (Drug) $44.01
- ANORO (Drug) $42.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lewiston
Dr. Jeffrey Michaud, Do, DO
Family Medicine — Payments: $5,950
Family Medicine $5,950
Dr. Robert Bull, Md, MD
Family Medicine — Payments: $5,628
Family Medicine $5,628
Dr. Albert Hartman, Md, MD
Family Medicine — Payments: $3,181
Family Medicine $3,181
Dr. Donald Greggain, M.d, M.D
Family Medicine — Payments: $2,587
Family Medicine $2,587
Dr. Stephen Murak, Md, MD
Family Medicine — Payments: $2,154
Family Medicine $2,154
Mina Assadollahzadeh, Do, DO
Family Medicine — Payments: $1,627
Family Medicine $1,627